# Cannabis and Alcohol Co-Use in Sexual-Minority Young Adults: What a National Study Found > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-alcohol-couse-sexual-minority-young-adults/ > **Published:** 2026-09-08T14:08:33-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:45:10-04:00 > **Clinical Summary:** cannabis alcohol co-use young adults: A national Monitoring the Future analysis followed 12,173 U.S. young adults and found higher cannabis-use and alcohol-c... --- CED Clinical Relevance #72 Notable Clinical Interest A peer-reviewed analysis of nationally representative Monitoring the Future panel data reports subgroup-specific prevalence and newly reported cannabis and alcohol co-use patterns, with clear observational and measurement limits. Clinical Insight | CED Clinic A national Monitoring the Future analysis followed 12,173 U.S. young adults and found higher cannabis-use and alcohol-cannabis co-use measures in several sexual-minority subgroups. Gay males and bisexual females had elevated odds of newly reported past-month co-use compared with heterosexual male and female reference groups. The observational study identifies screening and prevention needs but cannot establish that sexual identity or minority stress caused substance use. Its responsible clinical use is to support inclusive questions about actual behavior, timing, context, goals, and safety while resisting identity-based assumptions. CannabisAlcohol Co-UseYoung AdultsSexual-Minority HealthMonitoring the Future AudiencePatients, caregivers, clinicians, and cannabis-science readers interested in young-adult cannabis and alcohol use Primary Topicalcohol and cannabis use and co-use among sexual-minority young adults in the United States Source[Read the full source](https://pubmed.ncbi.nlm.nih.gov/42656640/) A national Monitoring the Future analysis followed 12,173 U.S. young adults and found higher cannabis-use and alcohol-cannabis co-use measures in several sexual-minority subgroups. Gay males and bisexual females had elevated odds of newly reported past-month co-use compared with heterosexual male and female reference groups. The observational study identifies screening and prevention needs but cannot establish that sexual identity or minority stress caused substance use. What This Study Teaches Us The analysis combined prevalence estimates with longitudinal-panel models among participants who reported no lifetime use at age 18. Bisexual females had the highest observed prevalence of past-month cannabis use, daily cannabis use, and past-month alcohol-cannabis co-use, while gay males and bisexual females had elevated adjusted odds of newly reported co-use relative to both heterosexual reference groups. Why This Matters Young adulthood remains an active period for the onset of cannabis use and alcohol-cannabis co-use. Disaggregated findings can support culturally responsive screening and prevention, but they should not be used to stereotype sexual-minority patients or assume a cause for any individual pattern. Study SnapshotStudy TypeObservational analysis of nationally representative longitudinal-panel survey dataPopulation12,173 U.S. young adults aged 19 to 30 in Monitoring the FutureData Years2019 to 2021Main ExposuresSelf-reported sexual identity and sexMain OutcomesPast-month alcohol use, binge drinking, cannabis use, daily cannabis use, and alcohol-cannabis co-usePast-Month Cannabis Use30.1 percent in the overall sampleDaily Cannabis Use11.7 percent in the overall samplePast-Month Co-Use26.0 percent in the overall sampleBisexual Female Prevalence47.8 percent cannabis use, 19.2 percent daily use, and 40.9 percent co-useIncident Co-UseElevated adjusted odds for gay males and bisexual females versus both heterosexual reference groupsPublishedAugust 7, 2026PMID42656640DOI10.1016/j.abrep.2026.100732 Clinical Bottom Line Several sexual-minority subgroups reported higher cannabis-use or co-use measures, particularly gay males and bisexual females. The findings support tailored, nonjudgmental screening and prevention while remaining observational, group-level evidence rather than individual prediction. The Study Separates Prevalence From Newly Reported Use The investigators reported current prevalence and also examined participants who had reported no lifetime alcohol or cannabis use at age 18. That second analysis asked whether disparities extended to use newly reported between ages 19 and 30. Because onset timing was not modeled and participants were not censored after first use, the authors describe these results as subsequently reported use rather than a precise age of initiation. That distinction keeps the longitudinal signal informative without overstating its timing. Bisexual Females Had the Highest Observed Cannabis Measures Among bisexual females, 47.8 percent reported past-month cannabis use, 19.2 percent reported daily use, and 40.9 percent reported past-month alcohol-cannabis co-use. These prevalences were higher than those for heterosexual female and male groups. The finding identifies a population-level disparity, not a defining feature of bisexual identity. Clinical use should focus on respectful questions about behavior, context, goals, and support rather than assumptions based on identity. Incident Co-Use Was Elevated in Two Subgroups Among respondents with no lifetime alcohol or cannabis use reported at age 18, gay males and bisexual females had elevated adjusted odds of newly reported past-month co-use relative to both heterosexual male and female reference groups. The study defines co-use as use of both substances during the same 30-day period. It does not establish that they were used at the same time, so the result should not be interpreted as a direct estimate of simultaneous intoxication or impairment. Observational Evidence Does Not Establish a Cause The models adjusted for age, survey year, region, urbanicity, race and ethnicity, parental education, educational attainment, and marital status. Adjustment can reduce measured confounding, but it cannot eliminate unmeasured differences or establish causal direction. The paper discusses minority stress and other possible pathways, but those mechanisms were not measured in this analysis. They remain hypotheses for future research rather than explanations proven by these data. How Strong Is This Evidence? The study uses a large national panel, disaggregates sexual-identity groups by sex, distinguishes current prevalence from newly reported use, applies survey weights, accounts for repeated observations, and uses Bonferroni correction for multiple comparisons. Where This Paper Deserves Skepticism Monitoring the Future begins with students enrolled in 12th grade, so young people who left school earlier are not represented. Small sexual-minority subgroups produced imprecise estimates, binary sex categories excluded gender-minority comparisons, co-use did not mean simultaneous use, and the observational analysis cannot establish causality. What This Paper Does Not Show The study does not show that sexual identity causes cannabis or alcohol use, that minority stress caused the reported patterns, that every person in a subgroup has elevated risk, or that past-month co-use means the substances were consumed simultaneously. It also does not test a treatment or prevention program. How This Fits With the Broader Clinical Conversation Substance-use disparities can reflect intersecting social conditions, stress exposure, trauma, community context, access to affirming care, and other factors. This study measures patterns by identity but does not directly test those pathways. The clinically responsible response is neither to ignore the group-level signal nor to turn it into a stereotype. It is to make screening more welcoming, specific, and useful for each person. Dr. Caplan’s Take *I read this paper as an invitation to improve the quality of screening. Asking about cannabis and alcohol together, including whether they are used during the same period or at the same time, can reveal safety concerns that a single-substance question misses.* *Identity should guide cultural humility, not prediction. Patients deserve affirming care that asks about their actual experiences, goals, stressors, supports, and risks without treating a population average as an individual diagnosis.* What a Careful Reader Should Take Away National panel data identified higher cannabis-use and alcohol-cannabis co-use measures in several sexual-minority young-adult subgroups, but the results are observational and should guide inclusive assessment rather than individual prediction. Evidence Interpretation Guide Table of Contents - [How to Interpret This Alcohol And Cannabis Use And Co-Use Among Sexual-Minority Young Adults In The United States Evidence Without Overstating It](#How_to_Interpret_This_Alcohol_And_Cannabis_Use_And_Co-Use_Among_Sexual-Minority_Young_Adults_In_The_United_States_Evidence_Without_Overstating_It)[A Four-Step Reading Frame](#A_Four-Step_Reading_Frame) - [Eight Ways to Read the Young-Adult Co-Use Evidence](#Eight_Ways_to_Read_the_Young-Adult_Co-Use_Evidence)[Identity Is Not a Diagnosis](#Identity_Is_Not_a_Diagnosis) - [Ask About Both Substances and Their Timing](#Ask_About_Both_Substances_and_Their_Timing) - [Longitudinal Data Still Need Careful Language](#Longitudinal_Data_Still_Need_Careful_Language) - [Disaggregation Reveals Uneven Patterns](#Disaggregation_Reveals_Uneven_Patterns) - [Risk Communication Must Avoid Stereotyping](#Risk_Communication_Must_Avoid_Stereotyping) - [Young Adulthood Remains an Active Window](#Young_Adulthood_Remains_an_Active_Window) - [Past-Month Co-Use Is Not Simultaneous Use](#Past-Month_Co-Use_Is_Not_Simultaneous_Use) - [Measure Mechanisms Instead of Assuming Them](#Measure_Mechanisms_Instead_of_Assuming_Them) - [Frequently Asked Questions](#Frequently_Asked_Questions)[Related](#Related) ## How to Interpret This Alcohol And Cannabis Use And Co-Use Among Sexual-Minority Young Adults In The United States Evidence Without Overstating It A useful evidence report should let the signal breathe without inflating it. The right question is not whether the paper is positive or negative, but what kind of decision it can responsibly support. ### A Four-Step Reading Frame **Evidence type**Start by identifying whether the paper is a randomized trial, review, meta-analysis, observational study, or protocol. **Population**Ask whether the studied population matches the patient or clinical scenario involving young-adult cannabis and alcohol use. **Outcome meaning**Look at what actually changed, how it was measured, and whether the change would matter in daily life. **Safety and uncertainty**Read limitations and adverse effects as part of the result, not as a footnote. The Research Question What does the current evidence suggest about alcohol and cannabis use and co-use among sexual-minority young adults in the United States? The Patient Question Does this mean I should use cannabinoids for young-adult cannabis and alcohol use? The Bottom Line The evidence can inform a careful conversation, but it does not replace individualized clinical care. CED Perspective Lens ## Eight Ways to Read the Young-Adult Co-Use Evidence Clinical, methodological, equity, prevention, and measurement perspectives Lens OverviewEach viewpoint stays within the peer-reviewed full text, preserves subgroup uncertainty, and distinguishes population disparities from individual prediction. #### Identity Is Not a Diagnosis A population study can identify groups that report different average patterns, but it cannot tell any individual what they use, why they use it, or what will happen next. Sexual-minority patients should not expect clinicians to infer substance use from identity or to treat disclosure as evidence of a disorder. The useful clinical conversation starts with permission and specificity: whether cannabis or alcohol is used, how often, whether use overlaps in the same month or the same occasion, what effects are desired, and what unwanted effects occur. The paper supports better questions, not identity-based conclusions. Lens takeawayUse the findings to invite respectful discussion, never to label an individual patient. #### Ask About Both Substances and Their Timing The study found that past-month alcohol-cannabis co-use was common in the overall sample and elevated in some subgroups. A single question about cannabis or alcohol alone can miss whether exposure overlaps and whether impairment, medication interactions, or competing goals become more complicated. Clinicians can distinguish use within the same 30-day period from simultaneous use during one occasion, which this study could not measure consistently. Screening should also cover frequency, quantity when known, route, motives, consequences, driving, mood, sleep, and readiness for change while preserving an affirming tone. Lens takeawaySeparate monthly co-use from simultaneous use and assess the safety context directly. #### Longitudinal Data Still Need Careful Language The panel followed respondents across young adulthood, but the incidence models did not measure the exact timing of initiation and did not censor people after their first reported use. The authors therefore estimate the odds of subsequently reported use among those reporting no lifetime use at age 18. That design is stronger than a single prevalence snapshot for showing that disparities can appear during young adulthood. It still cannot reconstruct a precise developmental trajectory or prove what preceded what. The most accurate phrase is newly reported use, not a confirmed moment of onset. Lens takeawayDescribe the longitudinal result as newly reported use, not precisely timed initiation. #### Disaggregation Reveals Uneven Patterns Combining all sexual-minority respondents into one category would obscure the study’s main finding: the largest and most consistent elevations were not uniform across groups. Bisexual females and gay males showed particularly notable cannabis or co-use measures, while other estimates were mixed or imprecise. Disaggregation can improve prevention planning, but small cells can also create unstable estimates. The other-identity groups each represented less than 2 percent of the sample, and some confidence intervals were wide. Equity-focused interpretation should preserve both visibility and statistical caution. Lens takeawayUse subgroup detail to improve services while keeping small-sample uncertainty visible. #### Risk Communication Must Avoid Stereotyping Research on disparities can unintentionally reinforce stigma when group averages are presented as inherent traits. This paper does not show that sexual-minority identity itself produces substance use, and it does not measure the mechanisms proposed in its discussion. Public-facing communication should emphasize modifiable contexts, access to affirming care, and individual assessment. It should avoid suggesting that gay, lesbian, bisexual, or other sexual-minority people are defined by substance use. A respectful interpretation treats the disparity as a reason to improve systems and conversations. Lens takeawayFrame disparities as a care-quality challenge, not as a trait of identity. #### Young Adulthood Remains an Active Window Among people reporting no lifetime use at age 18, several groups still showed elevated odds of newly reported cannabis use or co-use during ages 19 to 30. Prevention therefore cannot end at high-school graduation or assume that all patterns were established during adolescence. College, work, relationships, housing, community connection, and healthcare access can change rapidly during this period. The study does not test a specific prevention strategy, but it supports extending culturally responsive education, screening, and support into young-adult settings rather than focusing only on teenagers. Lens takeawayContinue affirming prevention and screening through the transitions of young adulthood. #### Past-Month Co-Use Is Not Simultaneous Use The co-use measure identified people who reported both alcohol and cannabis use during the previous 30 days. It did not establish whether the substances were consumed together, close in time, or on completely separate occasions. That boundary matters because simultaneous use may carry different impairment and safety implications. Readers should not convert the reported 26 percent overall co-use prevalence into a simultaneous-use estimate. Future surveys should capture timing, sequence, quantity, product type, and context more directly. Lens takeawayDo not interpret same-month exposure as proof of simultaneous alcohol and cannabis use. #### Measure Mechanisms Instead of Assuming Them The authors discuss minority stress, trauma, social context, and coping as possible contributors, but these constructs were not tested in the present analysis. Future studies should measure discrimination, support, mental health, motives, trauma exposure, community connection, and access to affirming services alongside substance-use patterns. Research should also include gender-minority participants with adequate sample sizes and follow people who were not enrolled in 12th grade. More precise timing and simultaneous-use measures would help distinguish developmental pathways and identify where prevention or clinical support can have the greatest effect. Lens takeawayFuture studies should test proposed pathways and include populations missing from this panel. Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion](https://cedclinic.com/interact/discussion-forums/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Share this Evidence Watch [X](https://twitter.com/intent/tweet?text=Cannabis+and+Alcohol+Co-Use+in+Sexual-Minority+Young+Adults%3A+What+a+National+Study+Found&url=https%3A%2F%2Fcedclinic.com%2Fcannabis-alcohol-couse-sexual-minority-young-adults%2F) [LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fcannabis-alcohol-couse-sexual-minority-young-adults%2F) [BlueSky](https://bsky.app/intent/compose?text=Cannabis+and+Alcohol+Co-Use+in+Sexual-Minority+Young+Adults%3A+What+a+National+Study+Found%20https%3A%2F%2Fcedclinic.com%2Fcannabis-alcohol-couse-sexual-minority-young-adults%2F) [Instagram](https://www.instagram.com/drcaplan/) [Substack](https://doctorapprovedcannabis.substack.com/) [RSS](https://cedclinic.com/feed/) Source: [Alcohol and cannabis use and Co-use among U.S. sexual minority young adults: Findings from the 2019-2021 Monitoring the Future longitudinal panel data](https://pubmed.ncbi.nlm.nih.gov/42656640/) Related Reading at CED ClinicContinue exploring the evidence[Cannabis Use and Mental Health in Young Canadian Adults: What a New Survey Found](https://cedclinic.com/canadian-young-adults-cannabis-mental-health-survey/) Recent CED coverage of cannabis-use frequency and self-reported mental health in a young-adult Canadian survey. [Compare young-adult evidence](https://cedclinic.com/canadian-young-adults-cannabis-mental-health-survey/)[Virtual Program Reduces Cannabis and Alcohol Use in Native American Emerging Adults](https://cedclinic.com/culturally-grounded-virtual-substance-use-intervention-native-american/) Related randomized evidence on a culturally grounded intervention addressing cannabis and alcohol use in emerging adults. [Review intervention evidence](https://cedclinic.com/culturally-grounded-virtual-substance-use-intervention-native-american/)[Insights on Cannabis Craving and Cross-Substance Use from Pooled Trial Data](https://cedclinic.com/cannabis-craving-cross-substance-use-analysis/) Earlier CED analysis of cannabis craving and cross-substance use patterns in pooled clinical-trial data. [Read cross-substance context](https://cedclinic.com/cannabis-craving-cross-substance-use-analysis/) Similar Studies on CEDClinic.comEarlier coverage on closely related evidence When a new paper overlaps with earlier CED Clinic coverage, we preserve the chain instead of hiding the overlap. These links point to older related posts so readers can compare what is new, what is repeated, and how the evidence has moved. Related digest item [Research Digest: 20 Recent Studies – May 02, 2026](https://cedclinic.com/cannabinoid-based-interventions-autism-safety-effectiveness-2026/) This research digest highlights cannabinoid-based interventions autism safety effectiveness from recent peer-reviewed studies. It covers clinical evidence on behavioral outcomes in children and adolescents with autism s… Covers a closely related topic; this CED post is older by about 97 days and gives earlier context. [Compare earlier coverage](https://cedclinic.com/cannabinoid-based-interventions-autism-safety-effectiveness-2026/) Related digest item [Multi-Modal Cannabis Use Among Young Adults: BRFSS 2022-2023](https://cedclinic.com/multi-modal-cannabis-use-young-adults-2023-patterns/) Multi-modal cannabis use young adults is increasingly common, with over half using multiple consumption methods. The 2022-2023 BRFSS survey reveals key patterns and risk factors. Understanding these trends is vital for… Covers a closely related topic; this CED post is older by about 106 days and gives earlier context. [Compare earlier coverage](https://cedclinic.com/multi-modal-cannabis-use-young-adults-2023-patterns/) ## Frequently Asked Questions What did the Monitoring the Future study examine? It examined alcohol use, cannabis use, daily cannabis use, and past-month alcohol-cannabis co-use among 12,173 U.S. young adults aged 19 to 30, comparing patterns across sex and sexual-identity groups. What did co-use mean in this study? Co-use meant reporting both alcohol and cannabis use during the same 30-day period. It did not necessarily mean using both substances simultaneously. How common was past-month cannabis use overall? Past-month cannabis use was reported by 30.1 percent of the overall sample. How common was daily cannabis use overall? Daily cannabis use, defined as at least 20 occasions in the previous 30 days, was reported by 11.7 percent of the overall sample. Which subgroup had the highest observed cannabis and co-use prevalence? Bisexual females had the highest observed prevalence of past-month cannabis use, daily cannabis use, and alcohol-cannabis co-use in the reported comparisons. What did the study find about newly reported co-use? Gay males and bisexual females had elevated adjusted odds of newly reported past-month co-use compared with both heterosexual male and heterosexual female reference groups. Does the study show that sexual identity causes substance use? No. Sexual identity was associated with group-level patterns, but the observational analysis cannot establish causation or prove the mechanisms discussed by the authors. Can these results predict an individual patient's behavior? No. Group averages cannot determine whether a particular person uses cannabis or alcohol, has a substance use disorder, or will experience harm. What are important study limitations? The cohort began with 12th-grade students, some subgroups were small, gender-minority comparisons were not included, co-use did not measure simultaneous use, and causal conclusions are not possible. How can clinicians use the findings responsibly? Clinicians can offer inclusive, nonjudgmental screening that asks about cannabis and alcohol together, clarifies timing and context, explores goals and consequences, and avoids assumptions based on identity. ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).